由于收益略低于预期，Applied Finance 在第二季度将其 Elevance Health 的股份削减了 14.9%。 Applied Finance cut its Elevance Health stake by 14.9% in Q2 amid slightly below-expected earnings.

应用金融资本管理有限公司将其在 " 提高健康 " (ELV)中的股份减少了14.9%,在Q2, 出售481股,持有价值107万美元的2 756股。 Applied Finance Capital Management LLC reduced its stake in Elevance Health (ELV) by 14.9% in Q2, selling 481 shares and holding 2,756 shares valued at $1.07 million. 该公司报告,Q2收入为每股8.84美元,略低于9.30的估计数,而收入逐年增加14.3%,达到494.2亿美元。 The company reported Q2 earnings of $8.84 per share, slightly below the $9.30 estimate, while revenue rose 14.3% year-over-year to $49.42 billion. Susan D. Devore董事以312.15美元购买了1 200股股票,使她的股份增加到3 502股,价值约109万美元。 Director Susan D. Devore bought 1,200 shares at $312.15, increasing her stake to 3,502 shares worth about $1.09 million. 股票关闭348.14美元,市场上限为78.39亿美元,P/E比率为14.81。 The stock closed at $348.14 with a market cap of $78.39 billion and a P/E ratio of 14.81. 分析员有一个协商一致的 " 机动购买 " 评级,目标价格为408.33美元。 Analysts have a consensus “Moderate Buy” rating with a target price of $408.33.